Campbell Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Campbell Wealth Management's PFE Position: Q4 2023 in Review
Campbell Wealth Management sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,630 shares — an estimated $220K sold.
Campbell Wealth Management first reported a position in PFE in Q4 2018 and held it in 20 quarters. The position peaked at $369K in Q2 2019. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Campbell Wealth Management reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- Campbell Wealth Management sold 6,630 Pfizer shares in Q4 2023, an estimated $220K.
- Campbell Wealth Management first reported a position in Pfizer in Q4 2018 and held it in 20 quarters.
- Campbell Wealth Management's Pfizer position peaked at $369K in Q2 2019.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Campbell Wealth Management's 13F filing for Q4 2023, filed 8 Feb 2024.